Related by context. All words. (Click for frequent words.) 79 dosing regimens 74 dosage regimens 73 dose regimens 69 dosing regimen 69 dosage regimen 67 dosing intervals 66 dosing 65 chemotherapeutic regimens 64 ritonavir boosted 64 decitabine 64 dose regimen 64 administered subcutaneously 64 dose cohorts 64 chemotherapy regimens 64 pegfilgrastim 64 subcutaneous dosing 64 therapeutic regimens 64 subcutaneous doses 64 subcutaneous injections 63 mg doses 63 mycophenolate mofetil 63 nab paclitaxel 63 intermittent dosing 63 ascending doses 63 subcutaneous SC 63 adalimumab 63 Pegasys ® 63 pharmacodynamic profile 62 docetaxel chemotherapy 62 tolerability 62 KAPIDEX 62 dose escalation 62 mitoxantrone 62 paclitaxel Taxol 62 ascending dose 62 pharmacokinetic profiles 62 platelet inhibitor 62 FOLPI 62 boosted protease inhibitor 62 Panzem R NCD 61 certolizumab 61 regimens 61 glatiramer acetate 61 APTIVUS r 61 tolerability profiles 61 oral rivaroxaban 61 dosing frequency 61 tipranavir 61 ibandronate 61 treatment regimens 61 double blinded placebo 61 #mg/m# [001] 61 anti leukemic 61 lapatinib Tykerb 61 abacavir lamivudine 61 protease inhibitor PI 61 intravenous dosing 61 HAART regimens 61 ganetespib 61 MIRCERA 60 administered orally 60 APTIVUS 60 cilengitide 60 subcutaneously administered 60 teriflunomide 60 letrozole Femara 60 temozolomide 60 AGILECT R 60 insulin degludec 60 oral dosing 60 vandetanib 60 tolerability profile 60 MYCAMINE 60 darunavir 60 visilizumab 60 PREZISTA r 60 placebo controlled clinical 60 pharmacokinetic profile 60 #mg dose [001] 60 #mg/m# [002] 60 Peg IFN 60 interferon alfa 2b 60 daunorubicin 60 infliximab Remicade 60 bendamustine 60 low dose cytarabine 60 NNRTIs 60 monotherapy 60 dexamethasone Decadron 60 insulin detemir 60 NRTIs 60 mealtime insulin 60 leucovorin 60 mcg doses 60 IV bolus 60 docetaxel Taxotere 60 optimal dosing 60 dosed orally 60 tigecycline 60 sorafenib Nexavar 59 dose limiting toxicities 59 azacitidine 59 lenalidomide dexamethasone 59 Dasatinib 59 chemotherapies 59 Neulasta ® 59 azathioprine 59 vicriviroc 59 INVEGA R 59 subcutaneous dose 59 subcutaneous formulation 59 placebo controlled studies 59 pegylated liposomal doxorubicin 59 antiepileptics 59 ZD# [001] 59 pertuzumab 59 bortezomib 59 nucleoside analog 59 forodesine 59 Pemetrexed 59 idarubicin 59 DAPT 59 fluticasone salmeterol 59 antiretroviral regimen 59 ISENTRESS 59 FOSRENOL ® 59 tramadol acetaminophen 59 pegylated interferon alfa 2a 59 q8h 59 antiviral efficacy 59 docetaxel Taxotere ® 59 dosing cohorts 59 AZOR 59 epoetin alfa 59 alpha 2a 59 CANCIDAS 59 coadministration 59 galiximab 59 interferon alfa 59 fluticasone furoate 59 pegylated interferon alfa 59 TMC# [001] 59 tenofovir emtricitabine 59 virologic failure 59 mcg kg 59 antiretroviral regimens 59 TREDAPTIVE 59 tapentadol ER 59 placebo controlled clinical trials 59 mg dose 58 tenofovir Viread 58 CR# vcMMAE 58 vorinostat 58 pharmacodynamic properties 58 SCH # 58 Capecitabine 58 stavudine d4T 58 mg/m2 dose 58 nelfinavir 58 temsirolimus 58 pegylated interferons 58 intramuscular injections 58 genotypic resistance 58 HAART regimen 58 oral ibandronate 58 dosing interval 58 uric acid lowering 58 nitazoxanide 58 fluorouracil 58 intravenous IV infusion 58 DMARD therapy 58 HGS# 58 REYATAZ R 58 dose cytarabine 58 AZILECT R 58 TELINTRA 58 hypofractionated 58 oral alendronate 58 amphotericin B 58 NEXIUM 58 Traficet EN 58 pomalidomide 58 ribavirin RBV 58 cytarabine 58 standard chemotherapy regimens 58 SPRYCEL 58 Dapagliflozin 58 paclitaxel cisplatin 58 LHRH antagonists 58 cidofovir 58 ZYVOX 58 buprenorphine naloxone 58 paclitaxel Taxol ® 58 docetaxel 58 pimozide 58 imipenem 58 INFERGEN 58 pharmacodynamics 58 placebo controlled trials 58 antiepileptic drugs AEDs 58 maximally tolerated dose 58 LEXIVA r 58 active comparator 58 carboplatin 58 sapacitabine 58 mesalamine granules 58 posaconazole 58 mg/m2/day 58 safety tolerability pharmacokinetics 58 timepoints 58 basal insulin 58 paricalcitol 58 antihypertensive drugs 58 dose titration 58 odanacatib 58 protease inhibitors PIs 58 fluvastatin 58 Fludara 58 mitomycin 58 nucleoside reverse transcriptase inhibitor 58 relapsed MM 58 concurrent chemoradiation 58 AZT zidovudine Retrovir 58 IFN beta 57 nevirapine Viramune 57 sipuleucel T 57 tacrolimus ointment 57 anakinra 57 interferon ribavirin 57 rituximab 57 secondary efficacy endpoints 57 primary hypercholesterolemia 57 BAY #-# 57 carboplatin paclitaxel 57 PEGASYS ® 57 inhibitor RG# 57 rFIXFc 57 octreotide LAR 57 analgesic efficacy 57 eniluracil 57 montelukast 57 heavily pretreated patients 57 etoposide 57 PEG Intron 57 immunosuppressive regimens 57 hematologic toxicities 57 chemotherapy regimen 57 oral iron chelator 57 pharmacokinetics 57 #mg/#mg 57 interferon alfa 2a 57 raltegravir 57 GFT# 57 epoetin 57 pharmacodynamics PD 57 esomeprazole 57 calcitriol 57 oral dosing regimen 57 bolus dose 57 INTELENCE 57 pharmacokinetic characteristics 57 dexpramipexole 57 antiemetics 57 doxorubicin cyclophosphamide 57 peg IFN 57 Mitoxantrone 57 pioglitazone Actos 57 alfa 2a 57 tanespimycin 57 Bezielle 57 aripiprazole 57 mg BID 57 q#h 57 LEXIVA 57 peginterferon alfa 2b 57 rituximab Rituxan 57 μg dose 57 intravitreal injection 57 VAPRISOL 57 atazanavir 57 rasagiline 57 immunomodulatory therapy 57 vinorelbine 57 COPAXONE R 57 adipiplon 57 steroid dexamethasone 57 leukotriene receptor antagonist 57 topiramate Topamax 57 direct thrombin inhibitors 57 desvenlafaxine succinate 57 velafermin 57 apremilast 57 piperacillin tazobactam 57 cediranib 57 Revlimid lenalidomide 57 atazanavir ritonavir 57 levothyroxine 57 Telintra 57 elvitegravir 57 Copegus ® ribavirin 57 lipid lowering agents 57 thromboprophylaxis 57 Interferon beta 1a 57 mg RDEA# 57 cinacalcet 57 BENICAR 57 fosamprenavir 57 ixabepilone 57 Laquinimod 57 Pegasys peginterferon alfa 2a 57 nucleoside analogs 57 DLTs 57 nebulized formoterol fumarate 57 LHRH analogues 57 Copegus ribavirin 57 mcg dose 57 Perforomist ™ Inhalation Solution 57 telcagepant 57 trastuzumab Herceptin ® 57 dasatinib 57 Combination therapy 57 preclinically 57 flutamide 57 mTOR inhibitors 57 venlafaxine Effexor 57 #mg doses [002] 57 GnRH agonists 57 CBLC# 57 darunavir ritonavir 57 budesonide formoterol 57 trastuzumab Herceptin 57 interferon beta 1b 57 Betaferon ® 56 mg/m2 56 Dacogen injection 56 lopinavir ritonavir 56 relapsing MS 56 irbesartan 56 INCB# [001] 56 BENICAR HCT 56 latrepirdine 56 Pharmacokinetics PK 56 tocilizumab 56 bicifadine 56 YONDELIS 56 caspofungin 56 dosages 56 romiplostim 56 blinded randomized placebo controlled 56 d4T stavudine Zerit 56 GAMMAGARD 56 TNF alpha inhibitor 56 antiangiogenic agents 56 VIRAMUNE XR 56 melphalan prednisone 56 bevacizumab Avastin ® 56 JANUVIA 56 sunitinib 56 saquinavir ritonavir 56 trials RCTs 56 fulvestrant 56 etanercept 56 FASLODEX 56 selegiline 56 antiepileptic drug 56 lixisenatide 56 Symadex 56 NPH insulin 56 levalbuterol 56 Elitek 56 Darunavir 56 liposomal formulation 56 antihypertensive agents 56 radezolid 56 cisplatin gemcitabine 56 inhaled fluticasone 56 dose placebo controlled 56 Hydroxyurea 56 long acting muscarinic 56 infliximab 56 LATUDA 56 ceftazidime 56 4mg/kg 56 ritonavir boosted atazanavir 56 bosentan 56 indacaterol 56 nilotinib 56 Taxotere ® 56 Pertuzumab 56 docetaxel Taxotere R 56 dose escalation trial 56 CHOP chemotherapy 56 treprostinil 56 placebo controlled Phase 56 Neupogen ® 56 AGILECT ® 56 phase Ib 56 baminercept 56 VELCADE 56 DU #b 56 zolmitriptan 56 DermaVir Patch 56 PRT# 56 clevidipine 56 NRTI 56 superficial bladder cancer 56 Diovan HCT 56 TNF inhibitor 56 belinostat 56 Fingolimod 56 REMINYL ® 56 inhalations twice 56 dopamine partial agonist 56 sirolimus 56 paliperidone palmitate 56 pramlintide metreleptin combination 56 sunitinib malate 56 antihypertensive medications 56 MoxDuo 56 proton pump inhibitor PPI 56 chemotherapeutic agents 56 colchicine 56 virological failure 56 bisphosphonate therapy 56 external beam radiotherapy 56 leflunomide 56 MIRAPEX ER 56 Elotuzumab 56 exenatide 56 FOLFIRI 56 octreotide 56 LPV r 56 cyclophosphamide 56 EGFR antibodies 56 epoetin beta 56 mg QD 56 eculizumab 56 bronchodilators 56 antitumor activity 56 anticancer therapies 56 idraparinux 56 Zileuton 56 rilpivirine 56 generation purine nucleoside 56 NGX# 56 suppressive therapy 56 Carfilzomib 56 antiviral activity 56 Fludarabine 56 angiogenesis inhibitor 56 lamotrigine 56 abacavir Ziagen 56 PXD# 56 Platinol 56 chemotherapeutics 56 Tarceva TM 56 pemetrexed 56 erlotinib Tarceva ® 56 vidofludimus 56 pyridostigmine 56 rifapentine 56 lamivudine 3TC 56 immunosuppressive agents 56 intravenously administered 56 mg administered orally 56 Teriflunomide 56 rFVIIa 56 peginterferon alfa 2a 56 pimecrolimus 56 pegylated 56 mesalamine 56 EFFEXOR XR 56 chlorthalidone 56 rotigotine 56 #mg dose [003] 56 pharmacokinetic parameters 56 interferon IFN 56 palonosetron 56 tolerated dose MTD 55 Lamictal XR 55 cytotoxic chemotherapy 55 glulisine 55 rt PA 55 topotecan 55 abatacept 55 Allovectin 7 ® 55 DMARDS 55 #mg ritonavir 55 neratinib 55 INVEGA SUSTENNA 55 deferoxamine 55 aplindore 55 antiretroviral agents 55 oral ribavirin 55 rHuPH# 55 evaluating REVLIMID 55 lopinavir r 55 LANTUS R 55 poliovirus vaccine 55 Locteron 55 biologic DMARD 55 insulin glargine rDNA origin 55 Omacetaxine mepesuccinate 55 tezampanel 55 sulfasalazine 55 IFN alpha 55 Dual Opioid 55 alvespimycin 55 CorVue ™ 55 Blinatumomab 55 pioglitazone HCl 55 Tekamlo 55 elotuzumab 55 infusional 55 GnRH agonist 55 chemotherapy docetaxel 55 mirtazapine 55 #mg q8h 55 mcg 55 Aptivus 55 nadolol 55 nucleoside analogues 55 erythropoietic agents 55 oral prodrug 55 efavirenz EFV 55 refractory NSCLC 55 Cloretazine 55 premixed insulin 55 telaprevir dosed 55 pharmacokinetic interactions 55 xenograft models 55 L DOPA 55 Pegylated Interferon 55 Sym# 55 gemcitabine 55 dacarbazine 55 atypical antipsychotic 55 FOLPI regimen 55 pan HDAC inhibitor 55 peginterferon alfa 2a #KD 55 evaluating Xcytrin 55 QVA# 55 epirubicin 55 MAO inhibitors 55 ponatinib 55 Vandetanib 55 adecatumumab 55 corifollitropin alfa 55 INVEGA ® 55 indibulin 55 chlorambucil 55 cardiac toxicity 55 ATACAND 55 naltrexone SR 55 chemoradiotherapy 55 ritonavir boosted lopinavir 55 Symbicort SMART 55 Taxotere R 55 raloxifene Evista 55 CIMZIA TM 55 nonrandomized 55 lipid lowering therapies 55 PROMACTA 55 metformin sulfonylurea 55 sorafenib tablets 55 ancrod 55 zileuton 55 efavirenz Sustiva 55 #I TM# 55 MIRAPEX 55 PREZISTA rtv 55 fondaparinux 55 FIRMAGON 55 rHuEPO 55 Phase 1b trial 55 zonisamide SR 55 continuous intravenous infusion 55 BEACOPP 55 CYT# 55 PEGINTRON 55 RISPERDAL ® 55 corticosteroid therapy 55 phase IIb clinical 55 AIR# [001] 55 anticonvulsant medications 55 allopurinol 55 low dose ritonavir 55 flecainide 55 GLP1 agonist 55 tecarfarin 55 pyrazinamide 55 mg m² 55 tirofiban 55 salmeterol fluticasone 55 adriamycin 55 SEROQUEL XR 55 tolvaptan 55 ritonavir boosting 55 myopathy rhabdomyolysis 55 pregabalin Lyrica 55 Exenatide Byetta 55 beclomethasone dipropionate 55 gemcitabine carboplatin 55 DEXILANT 55 FOLOTYN 55 Cytoxan 55 BROVANA 55 APRISO 55 SCIg 55 zidovudine AZT 55 Vidaza azacitidine 55 dose proportional pharmacokinetics 55 LEP ETU 55 divalproex sodium 55 LEVADEX 55 TAFA# 55 budesonide 55 NVA# 55 rifabutin 55 intra articular injections 55 BMS # 55 VELCADE melphalan 55 CA4P 55 TMC# r 55 voriconazole 55 integrase inhibitor 55 Tarceva erlotinib 55 albinterferon alfa 2b 55 motesanib 55 Doxil ® 55 pazopanib 55 CoFactor 55 Insulin PH# 55 levetiracetam 55 5FU 55 abacavir 55 combinability 55 intramuscular 55 LY# [003] 55 REOLYSIN ® 55 mycophenolate mofetil MMF 55 PEG IFN 55 SRT# [003] 55 FOSRENOL R 55 PEG Interferon lambda 55 conventional antipsychotics 55 double blinded randomized 55 BoNTA 55 Asentar 55 bronchodilation 55 obatoclax 55 KRN# 55 aspirin clopidogrel 55 Epoetin alfa 55 overlapping toxicities 55 eszopiclone 55 citalopram Celexa 55 intravenous bisphosphonates 55 paclitaxel poliglumex 55 AeroLEF TM 55 IIIa inhibitor 55 multidose 55 intravenous infusion 55 IRESSA 55 LCP Tacro ™ 55 Torisel 55 pharmacodynamic markers 55 oxymorphone ER 55 5-FU/LV 55 mg q8h 55 DMARD 55 sitagliptin 55 ketorolac 55 Inhalation Solution 55 GRN#L 55 zafirlukast 55 efficacy tolerability 55 biologic DMARDs 55 IMC A# 55 Pentacel vaccine 55 AMEVIVE 55 olaparib 55 leukotriene receptor antagonists 55 venlafaxine ER 55 pharmacokinetics PK 55 Phase III Clinical Trials 55 L dopa 55 convenient dosing regimen 55 paclitaxel eluting stents 55 pramlintide 55 Protelos 55 relapsed ovarian cancer 55 Tekturna HCT 55 APTIVUS R 55 EVIZON 55 sorafenib Nexavar ® 55 ACTEMRA TM 55 oral deforolimus 55 Pegasys R 55 adefovir 55 gemcitabine Gemzar 55 trabectedin 55 Targretin 55 lispro 55 stavudine 55 non inferiority 55 Phase Ib II 55 weekly subcutaneous injections 55 viral kinetics 55 inhaled corticosteroid ICS 55 oral antidiabetic 55 hour bronchodilation 55 relapsing multiple sclerosis 55 AEGR 55 GSK# [001] 54 timolol 54 ceftriaxone 54 antiandrogen 54 virologic suppression 54 Enhanze Technology 54 TORISEL 54 6mg 54 diabetic neuropathic pain 54 intravenous cyclophosphamide 54 immunomodulatory therapies 54 dose dose escalation 54 prucalopride 54 Phase Ib clinical 54 Perforomist TM Inhalation Solution 54 CTAP# Capsules 54 strontium ranelate 54 IMGN# 54 efalizumab 54 Twinrix 54 Quetiapine 54 Phase IIb trials 54 vandetanib #mg 54 antidepressant therapy 54 phosphate binders 54 budesonide foam 54 bicalutamide 54 VFEND 54 neoadjuvant 54 Lantus R 54 PEG INTRON 54 hA# 54 edoxaban 54 Focalin XR 54 goserelin 54 receptor tyrosine kinase inhibitor 54 pharmacodynamic effects 54 amoxicillin clavulanate 54 5 fluorouracil 54 RG# ITMN 54 ropinirole 54 lintuzumab 54 pharmacologically active isomer 54 Phase 2a trial 54 Xelox 54 molecular weight heparins 54 phase IIa clinical 54 alkylating agent 54 primary efficacy endpoints 54 bisphosphonate 54 Platinol ® cisplatin 54 XEOMIN 54 phenytoin 54 enzastaurin 54 Xanafide 54 Durezol 54 rFSH 54 APOPTONE 54 randomized #:#:# 54 FOLFOX6 54 cytarabine daunorubicin 54 Imprime PGG 54 pharmacokinetic properties 54 Rifampin 54 telaprevir dosing 54 viral kinetic 54 TELCYTA 54 corticosteroids 54 SUSTENNA TM 54 doxorubicin docetaxel 54 tiotropium 54 typical antipsychotics 54 Oxaliplatin 54 saquinavir 54 BRAF inhibitor 54 Hematologic toxicity 54 Pegasys plus Copegus 54 telbivudine 54 luteinizing hormone releasing 54 NSABP B 54 bevacizumab Avastin 54 ACTEMRA 54 Interferon alpha 54 Neuradiab 54 thromboembolic events 54 virologic response 54 #.#mg dose 54 olanzapine LAI 54 prasugrel Effient 54 oral antidiabetes drugs 54 HCV RESPOND 2 54 GEM OS2 54 ritonavir boosted protease inhibitor 54 otelixizumab 54 atorvastatin #mg 54 atazanavir sulfate 54 thalidomide Thalomid 54 GnRH antagonist 54 PegIFN 54 PRISTIQ 54 TPI ASM8 54 ethambutol 54 NeoRecormon 54 pharmacodynamic PD 54 estramustine 54 oral levofloxacin 54 oral prednisone 54 induce remission 54 zoledronic acid 54 teriparatide 54 β blockers 54 concomitant medications 54 PRADAXA 54 #mg/day [001] 54 5 FU 54 Navelbine ® 54 TPV r 54 INTUNIV 54 lamivudine 54 corticosteroid dexamethasone 54 LMWH 54 factorial design 54 blind randomized placebo 54 amprenavir 54 Irinotecan 54 DMARDs 54 danazol 54 bromocriptine 54 LIALDA 54 calcineurin inhibitors 54 cisplatin chemotherapy 54 COMBIVIR 54 Byetta exenatide 54 Cloretazine R VNP#M 54 Arixtra 54 teduglutide 54 pramipexole 54 propafenone 54 Phase Ib study 54 tamoxifen Nolvadex ® 54 Noxafil 54 ABVD 54 antisense compounds 54 tolterodine ER 54 Bortezomib 54 randomized trials 54 TLR agonists 54 Doxil 54 nicardipine 54 zidovudine 54 Gabapentin GR 54 rituximab Rituxan ® 54 oral ridaforolimus 54 formoterol fumarate 54 MoxDuo TM IR 54 pamidronate 54 BeneFIX 54 noninferiority 54 CONCERTA 54 Hycamtin 54 cholestyramine 54 DermaVir 54 EOquin TM 54 oxcarbazepine 54 dopamine agonist 54 taxotere 54 trabedersen 54 mapatumumab 54 AZILECT 54 macrolide antibiotics 54 darunavir Prezista 54 Apidra R 54 peginterferon alfa 2a Pegasys 54 alpha 2b 54 infrequent dosing 54 investigational monoclonal antibody 54 paclitaxel Taxol R 54 ug kg 54 mg kg dose 54 pharmacokinetic PK profile 54 serotonin norepinephrine reuptake inhibitor 54 rosuvastatin Crestor 54 antiplatelet drugs 54 Tiotropium 54 dasatinib Sprycel ® 54 pharmacodynamic 54 ara C 54 atazanavir Reyataz 54 axitinib 54 lamivudine zidovudine 54 oral anticoagulants 54 NXL# 54 TCAD therapy 54 subgroup analyzes 54 blinded placebo controlled 54 antitumor efficacy 54 topical calcineurin inhibitors 54 cannabinor 54 indinavir Crixivan 54 trastuzumab 54 Phase Ib 54 MEVACOR 54 eprotirome 54 levodopa therapy 54 S/GSK# 54 metastatic CRC 54 Exenatide 54 tenofovir DF 54 adalimumab Humira 54 escitalopram Lexapro 54 Q2W 54 primidone 54 ziprasidone 54 dose proportionality 54 exemestane Aromasin 54 cilostazol 54 KRAS status 54 insulin glargine 54 brivaracetam 54 PEGINTRON TM 54 Mylotarg 54 epoetin alpha 54 dasatinib Sprycel 54 KB# [002] 54 Oral corticosteroids 54 oral anticoagulation 54 Dosing 54 RAPTIVA 54 androgen suppression 54 PEG SN# 54 PRECiSE 54 NATRECOR R 54 8mg/kg 54 NRTI backbone 54 SPRYCEL ® 54 cetuximab 54 Vidaza ® 54 palivizumab 54 Neoadjuvant 54 phase IIIb 54 aripiprazole Abilify 54 tenofovir TDF 54 Zoledronic acid 54 gemcitabine chemotherapy 54 OMP #M# 54 REVLIMID lenalidomide 54 LTRA 54 alpha blocker 54 DACH platinum 54 chemotherapeutic regimen 54 Pazopanib 54 NOXAFIL 54 GW# [003] 54 MEK inhibitors 54 TDF FTC 54 citalopram 54 Melphalan 54 rabeprazole 54 MAS XR 54 intradermal injection 54 ELOXATIN 54 CG# [003] 54 SEROQUEL 54 PEGylated interferon beta 1a 54 Salmeterol 54 Phase 2b dose 54 heavily pretreated 54 picoplatin 54 demonstrated clinically meaningful 54 Pegylated interferon 54 pegylated interferon 54 oral antidiabetic agents 54 bupropion SR 54 long acting bronchodilator 54 cobicistat 54 Tavocept 54 5 FU leucovorin 54 taxanes 54 EMSAM 54 lomitapide 54 rindopepimut 54 randomized Phase III 54 Capesaris 54 inhaled budesonide 54 peginterferon alpha 2a